Salt-inducible kinase 2 (SIK2) inhibitor ARN-3236 attenuates bleomycin-induced pulmonary fibrosis in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Salt-inducible kinase 2 (SIK2) inhibitor ARN-3236 attenuates bleomycin-induced pulmonary fibrosis in mice ; volume:22 ; number:1 ; day:11 ; month:4 ; year:2022 ; pages:1-11 ; date:12.2022
BMC pulmonary medicine ; 22, Heft 1 (11.4.2022), 1-11, 12.2022
- Urheber
-
Zou, Liangneng
Hong, Dequn
Li, Kecong
Jiang, Bingyuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-022-01940-0
- URN
-
urn:nbn:de:101:1-2022062623080414622109
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zou, Liangneng
- Hong, Dequn
- Li, Kecong
- Jiang, Bingyuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Inhibition or knock out of Inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Bleomycin-induced genome structural variations in normal, non-tumor cells
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
A critical role of AREG for bleomycin-induced skin fibrosis
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Inhibition or knock out of Inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Bleomycin-induced genome structural variations in normal, non-tumor cells
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
A critical role of AREG for bleomycin-induced skin fibrosis
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Inhibition or knock out of Inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Bleomycin-induced genome structural variations in normal, non-tumor cells
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
A critical role of AREG for bleomycin-induced skin fibrosis
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice